US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by XTL Biopharmaceuticals Ltd.

News headline image
XTL Completed the Acquisition of Psyga Bio Ltd.
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
Tickers XTLB
News headline image
XTL Announces Receipt of Staff Delist Determination from Nasdaq
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
Tickers XTLB
News headline image
XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
Tickers XTLB
News headline image
XTL Biopharmaceuticals Announces ADS Ratio Change
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
Tickers XTLB
News headline image
XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
Tickers XTLB
News headline image
XTL Update on Recent Developments
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
Tickers XTLB
News headline image
XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
Tickers XTLB
News headline image
XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
Tickers XAIR XTLB
News headline image
XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
Tickers XTLB
News headline image
XTL Names Mr. Noam Band as its New Chief Executive Officer
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
Tickers XTLB
News headline image
XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
Tickers XTLB
News headline image
XTL Entered Definitive Agreement to Acquire The Social Proxy
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
Tickers XTLB
News headline image
XTL To Aquire The Social Proxy
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
Tickers XTLB
News headline image
XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
Tickers XTLB
News headline image
XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
Tickers XTLB